Gilead Sciences, Inc.

NasdaqGS:GILD

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 148.54 B

Share Price

USD 119.41

Avg Daily Volume

7,602,396

Change (1 day)

8.28%

Change (1 year)

57.97%

Change (YTD)

29.27%

Gilead Sciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 10.37 B

Gilead Sciences, Inc. Operating Cash Flow is USD 10.37 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 22.23% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Gilead Sciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 8.48 B, a -5.51% change year over year.
Gilead Sciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 8.98 B, a -15.43% change year over year.
Gilead Sciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 10.61 B, a 13.62% change year over year.
Gilead Sciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 9.34 B, a 3.77% change year over year.